Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

  • This share is currently suspended. It was suspended at a price of 2,450.00
  • There is currently no data for FDP

New Investment - Replacement

29 Jan 2009 10:07

RNS Number : 4511M
First Derivatives PLC
29 January 2009
 



29 January 2009

First Derivatives plc

(AIM:FDP.L, IEX:GYQ.I)

New Investment

This announcement is released as a replacement for RNS 4232M which was released under a misleading RNS heading. 

First Derivatives plc ("FDP" or the "Company") is pleased to announce that it has secured financial support from Invest Northern Ireland (Northern Ireland's Economic Development Agency) towards the recruitment and training of additional staff. FDP is a leading provider of consultancy and software solutions to the capital markets industry. With a focus on financial institutions, the Company develops, implements and supports a broad range of mission critical trading and risk management systems across front, middle and back-office operations for many of the world's leading financial institutions.

The commitment from Invest Northern Ireland is for over £3.0 million and is to support the Company in the creation of 132 new consultancy positions and 10 new managerial posts over the next 2.5 years. A proportion of the funds, provided by the European Regional Development Fund, is also focused toward the development of staff skills to ensure FDP continues to add to its highly skilled and knowledgeable workforce. 

Chief Executive Brian Conlon said: "Over the last 12 years FDP has developed a recognized brand in the financial services sector. Our niche products and services continue to enjoy strong demand. Critical to this success has been innovation across all areas of the business, as well as significant investment in training and development. I am delighted that Invest Northern Ireland is supporting us in the further development of our business. This financial support will assist us as we continue with our global growth plans."

Contact:

First Derivatives plc

Brian Conlon

Tel: +44 (0)28 3025 2242

Charles Stanley Securities

Nominated Adviser

Russell Cook/Carl Holmes

Tel: +44 (0)20 7149 6000

Goodbody Stockbrokers 

IEX Adviser

Diane Hodgson/Linda Hickey

Tel: +353 1 667 0420

Stakeholder Communications 

Carl Whyte 

Lisa Nugent

Tel: +44 (0)28 9033 9949

Tel: +44 (0) 20 7903 5148

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBKLFLKFBBBBF
Date   Source Headline
2nd Oct 20237:00 amRNSNotice of Results
31st Aug 20239:18 amRNSTotal Voting Rights
15th Aug 20237:00 amRNSIssue of Equity
31st Jul 20231:59 pmRNSTotal Voting Rights
20th Jul 20233:30 pmRNSResult of AGM
28th Jun 20234:17 pmRNSPDMR Notice and Issue of Equity
27th Jun 20234:30 pmRNSNotice of AGM
5th Jun 202312:43 pmRNSHolding(s) in Company
30th May 20231:01 pmRNSHolding(s) in Company
23rd May 20237:00 amRNSResults for the year ended 28 February 2023
18th May 20237:00 amRNSKX partnering with Amazon Web Services
5th Apr 20237:00 amRNSLTIP Award
4th Apr 20231:51 pmRNSHolding(s) in Company
4th Apr 20237:00 amRNSFY23 trading update
20th Mar 20237:00 amRNSGeneral availability of kdb Insights Enterprise
28th Feb 20238:39 amRNSTotal Voting Rights
13th Feb 20234:43 pmRNSIssue of Equity
30th Dec 202210:06 amRNSTotal Voting Rights
22nd Dec 20224:15 pmRNSHolding(s) in Company
20th Dec 20224:02 pmRNSIssue of Equity
14th Dec 20222:01 pmRNSHolding(s) in Company
30th Nov 20228:47 amRNSTotal Voting Rights
15th Nov 20227:00 amRNSIssue of Equity
31st Oct 20227:00 amRNSDirector/PDMR Shareholding
21st Oct 202211:38 amRNSDirector/PDMR Shareholding
18th Oct 20227:00 amRNSResults for the six months ended 31 August 2022
6th Oct 20222:02 pmRNSHolding(s) in Company
22nd Sep 20228:06 amRNSHolding(s) in Company
7th Sep 20227:00 amRNSNotice of Results
31st Aug 202210:09 amRNSTotal Voting Rights
16th Aug 20225:50 pmRNSIssue of Equity
5th Aug 20227:00 amRNSAppointment of Ashok Reddy as CEO of KX
2nd Aug 20229:49 amRNSHolding(s) in Company
29th Jul 202210:43 amRNSTotal Voting Rights
19th Jul 20227:00 amRNSIssue of Equity
7th Jul 20223:24 pmRNSResult of AGM
30th Jun 202212:30 pmRNSTotal Voting Rights
23rd Jun 20226:01 pmRNSIssue of Equity
8th Jun 20223:43 pmRNSNotice of AGM
31st May 202210:18 amRNSTotal Voting Rights
23rd May 20226:31 pmRNSRNS PDMR notice Issue of Equity
10th May 20227:00 amRNSResults for the year ended 28 February 2022
3rd May 20223:00 pmRNSHolding(s) in Company
26th Apr 20226:17 pmRNSHolding(s) in Company
11th Apr 20226:28 pmRNSTR1 - Notification of Major Holdings
6th Apr 20227:00 amRNSTrading update
5th Apr 20227:00 amRNSHolding(s) in Company
1st Mar 20227:00 amRNSKX Strategic Partnership Agreement with Microsoft
28th Feb 20225:52 pmRNSIssue of Equity
3rd Feb 20221:04 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.